• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现非激素男性避孕药分子靶点的各种基因编辑技术:综述

Various gene modification techniques to discover molecular targets for nonhormonal male contraceptives: A review.

作者信息

Yunaini Luluk, Ari Pujianto Dwi

机构信息

Doctoral Program of Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Indonesia.

Department of Medicine Biology, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Indonesia.

出版信息

Int J Reprod Biomed. 2023 Feb 8;21(1):17-32. doi: 10.18502/ijrm.v21i1.12662. eCollection 2023 Jan.

DOI:10.18502/ijrm.v21i1.12662
PMID:36875503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9982321/
Abstract

The identification and characterization of relevant targets are necessary for developing nonhormonal male contraceptives. The molecules must demonstrate that they are necessary for reproduction. As a result, a sophisticated technique is required to identify the molecular targets for nonhormonal male contraceptives. Genetic modification (GM) techniques are one method that can be applied. This technique has been widely used to study gene function that effected male fertility and has resulted in the discovery of numerous nonhormonal male contraceptive target molecules. We examined GM techniques and approaches used to investigate genes involved in male fertility as potential targets for nonhormonal contraceptives. The discovery of nonhormonal contraceptive candidate molecules was increased by using GM techniques, especially the Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 method. The discovery of candidate nonhormonal contraceptive molecules can be a wide-open research for the development of nonhormonal male contraceptives. Therefore, we are believing that one day nonhormonal male contraceptives will be released.

摘要

确定和表征相关靶点对于开发非激素男性避孕药是必要的。这些分子必须证明它们对生殖是必需的。因此,需要一种复杂的技术来识别非激素男性避孕药的分子靶点。基因编辑(GM)技术是一种可以应用的方法。该技术已被广泛用于研究影响男性生育能力的基因功能,并导致发现了许多非激素男性避孕靶点分子。我们研究了用于研究参与男性生育的基因作为非激素避孕药潜在靶点的基因编辑技术和方法。通过使用基因编辑技术,特别是成簇规律间隔短回文重复序列/Cas9方法,增加了非激素避孕候选分子的发现。非激素避孕候选分子的发现对于非激素男性避孕药的开发可能是一个广阔的研究领域。因此,我们相信有一天非激素男性避孕药将会问世。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b79/9982321/16e0940aec31/ijrb-21-17-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b79/9982321/9d66b729cf73/ijrb-21-17-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b79/9982321/d27815218c4e/ijrb-21-17-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b79/9982321/116aaaba270f/ijrb-21-17-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b79/9982321/16e0940aec31/ijrb-21-17-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b79/9982321/9d66b729cf73/ijrb-21-17-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b79/9982321/d27815218c4e/ijrb-21-17-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b79/9982321/116aaaba270f/ijrb-21-17-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b79/9982321/16e0940aec31/ijrb-21-17-g004.jpg

相似文献

1
Various gene modification techniques to discover molecular targets for nonhormonal male contraceptives: A review.发现非激素男性避孕药分子靶点的各种基因编辑技术:综述
Int J Reprod Biomed. 2023 Feb 8;21(1):17-32. doi: 10.18502/ijrm.v21i1.12662. eCollection 2023 Jan.
2
Approaches to the identification of new nonhormonal targets for male contraception.鉴定男性避孕新非激素靶点的方法。
Contraception. 2008 Oct;78(4 Suppl):S18-22. doi: 10.1016/j.contraception.2008.05.001. Epub 2008 Jun 12.
3
The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve.口服避孕药对磨牙后人绒毛膜促性腺激素消退曲线的影响。
Am J Obstet Gynecol. 1985 Apr 1;151(7):906-14. doi: 10.1016/0002-9378(85)90669-6.
4
Optimization of lead compounds into on-demand, nonhormonal contraceptives: leveraging a public-private drug discovery institute collaboration†.将先导化合物优化为按需、非激素避孕药物:利用公私药物研发机构合作。
Biol Reprod. 2020 Aug 4;103(2):176-182. doi: 10.1093/biolre/ioaa052.
5
New IPPF statement on breastfeeding, fertility and post-partum contraception.国际计划生育联合会关于母乳喂养、生育力和产后避孕的新声明。
IPPF Med Bull. 1990 Apr;24(2):2-4.
6
Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents.用于持续释放非激素避孕药和抗艾滋病毒药物的阴道环的研发。
Contraception. 2007 Aug;76(2):132-8. doi: 10.1016/j.contraception.2007.04.006. Epub 2007 Jun 27.
7
Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.哺乳期联合激素避孕、非激素避孕与单纯孕激素避孕的比较
Cochrane Database Syst Rev. 2003(2):CD003988. doi: 10.1002/14651858.CD003988.
8
Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Gene Editing Technique in Xenotransplantation.簇状规律间隔短回文重复序列/ Cas9 基因编辑技术在异种移植中的应用。
Front Immunol. 2018 Sep 5;9:1711. doi: 10.3389/fimmu.2018.01711. eCollection 2018.
9
Steroidal contraceptives and bone fractures in women: evidence from observational studies.甾体避孕药与女性骨折:来自观察性研究的证据
Cochrane Database Syst Rev. 2012 Aug 15(8):CD009849. doi: 10.1002/14651858.CD009849.pub2.
10
Male Contraceptive Development: Update on Novel Hormonal and Nonhormonal Methods.男性避孕药具的发展:新型激素和非激素方法的最新进展。
Clin Chem. 2019 Jan;65(1):153-160. doi: 10.1373/clinchem.2018.295089.

本文引用的文献

1
Mouse CD52 is Predominantly Expressed in the Cauda Epididymis, Regulated by Androgen and Lumicrine Factors.小鼠CD52主要在附睾尾部表达,受雄激素和腔分泌因子调控。
J Hum Reprod Sci. 2021 Oct-Dec;14(4):350-355. doi: 10.4103/jhrs.jhrs_29_21. Epub 2021 Dec 31.
2
Update on Novel Hormonal and Nonhormonal Male Contraceptive Development.新型激素和非激素男性避孕药的最新进展。
J Clin Endocrinol Metab. 2021 May 13;106(6):e2381-e2392. doi: 10.1210/clinem/dgab034.
3
Stopping sperm at the source.从源头阻止精子。
Nature. 2020 Dec;588(7838):S170-S171. doi: 10.1038/d41586-020-03534-4.
4
Mouse defensin beta 20 (Defb20) is expressed specifically in the caput region of the epididymis and regulated by androgen and testicular factors.鼠防御素β 20(Defb20)特异性表达于附睾头部,受雄激素和睾丸因子调控。
Reprod Biol. 2020 Dec;20(4):536-540. doi: 10.1016/j.repbio.2020.09.003. Epub 2020 Oct 12.
5
Retinoic acid receptor antagonists for male contraception: current status†.维甲酸受体拮抗剂用于男性避孕:现状†。
Biol Reprod. 2020 Aug 4;103(2):390-399. doi: 10.1093/biolre/ioaa122.
6
Sperm proteins SOF1, TMEM95, and SPACA6 are required for sperm-oocyte fusion in mice.精子蛋白 SOF1、TMEM95 和 SPACA6 对于小鼠精卵融合是必需的。
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11493-11502. doi: 10.1073/pnas.1922650117. Epub 2020 May 11.
7
Testis-specific serine kinase protein family in male fertility and as targets for non-hormonal male contraception†.睾丸特异性丝氨酸激酶蛋白家族与男性生育及作为非激素男性避孕靶点。
Biol Reprod. 2020 Aug 4;103(2):264-274. doi: 10.1093/biolre/ioaa064.
8
Optimization of lead compounds into on-demand, nonhormonal contraceptives: leveraging a public-private drug discovery institute collaboration†.将先导化合物优化为按需、非激素避孕药物:利用公私药物研发机构合作。
Biol Reprod. 2020 Aug 4;103(2):176-182. doi: 10.1093/biolre/ioaa052.
9
Spermatozoa lacking Fertilization Influencing Membrane Protein (FIMP) fail to fuse with oocytes in mice.缺乏受精影响膜蛋白(FIMP)的精子无法与卵母细胞在小鼠中融合。
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9393-9400. doi: 10.1073/pnas.1917060117. Epub 2020 Apr 15.
10
HIPK4 is essential for murine spermiogenesis.HIPK4 对于小鼠精子发生是必需的。
Elife. 2020 Mar 12;9:e50209. doi: 10.7554/eLife.50209.